Home › Studies › PRJNA1268178
PRJNA1268178 SRP587838

Multi-donor FMT trial in anorexia nervosa, Auckland NZ

Gut Bugs in Anorexia Nervosa Trial

98 stool samples from an open-label feasibility pilot trial of encapsulated, multi-donor faecal microbiota transfer in young women with anorexia nervosa in Auckland, New Zealand. machine-written summary

98 samples · 98 runs · NZ · Adult · 2025 · 5.97 Gbp / sample

Sources
✓Sequence archive 613✓Abstract / description 196✓Full text 196○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive613 sample values (collection date, country, intervention, intervention detail, location locality, subject id, timepoint)
✓ Abstract / description196 sample values (health condition, health condition detail)
✓ Full text196 sample values (location site, sex) · PMC12808231
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

before · no interventionbefore · no interventi29 samplesFMTFMT63 samples
single arm: samples before and on the intervention

Faecal microbiota transplantation design single_arm_before_after · population other_disease · Encapsulated multi-donor faecal microbiota transfer, 20 capsules/4 donors

“capsule-delivered, multi-donor FMT intervention” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult98
Condition
other_disease98
Sex
female98
Country
NZ98
Body site
primary98
Collected 2022–2024
2022: 41 samples2023: 48 samples2024: 9 samples20222024
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 98 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 5.97 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinalFMT donor → recipient — not resolved

26 of 37 people sampled more than once (87 samples; median 3, up to 5 per person) · follow-up median 3 mo (max 11 mo) · median interval between samples 23 d (time from collection dates). Schedule stated by the source: “Stool collected at enrolment (3wk pre-treatment), baseline, and 3, 6, 12 weeks post-treatment.”.

AN-F01AN-F01: day 0AN-F01: day 24AN-F01: day 52AN-F01: day 67AN-F01: day 111AN-F02AN-F02: day 0AN-F02: day 25AN-F02: day 50AN-F02: day 74AN-F03AN-F03: day 0AN-F03: day 24AN-F03: day 45AN-F03: day 69AN-F03: day 105AN-F04AN-F04: day 0AN-F04: day 26AN-F04: day 47AN-F04: day 67AN-F04: day 110AN-F05AN-F05: day 0AN-F05: day 21AN-F07AN-F07: day 0AN-F07: day 21AN-F07: day 44AN-F07: day 63AN-F07: day 106AN-F09AN-F09: day 0AN-F09: day 15AN-F09: day 49AN-F09: day 64AN-F09: day 100AN-F10AN-F10: day 0AN-F10: day 20AN-F10: day 42AN-F10: day 64AN-F10: day 102AN-F11AN-F11: day 0AN-F11: day 20AN-F12AN-F12: day 0AN-F12: day 21AN-F12: day 39AN-F12: day 105AN-F13AN-F13: day 0AN-F13: day 22AN-F13: day 45AN-F13: day 61AN-F13: day 101AN-F14AN-F14: day 0AN-F14: day 22AN-F14: day 42AN-F14: day 64AN-F14: day 106AN-F15AN-F15: day 0AN-F15: day 21AN-F15: day 43AN-F15: day 64AN-F15: day 107AN-F16AN-F16: day 0AN-F16: day 20AN-F17AN-F17: day 0AN-F17: day 21AN-F17: day 63AN-F17: day 107CP-F01CP-F01: day 0CP-F01: day 140CP-F03CP-F03: day 0CP-F03: day 1CP-F03: day 169CP-F21CP-F21: day 0CP-F21: day 325CP-F22CP-F22: day 0CP-F22: day 163DN-F01DN-F01: day 0DN-F01: day 140DN-F03DN-F03: day 0DN-F03: day 1DN-F03: day 169DN-F21DN-F21: day 0DN-F21: day 325DN-F22DN-F22: day 0DN-F22: day 163Zymo-GutMicrobioZymo-GutMicrobiomeStandard-D6331: day 0Zymo-GutMicrobiomeStandard-D6331: day 8Zymo-MicrobialCoZymo-MicrobialCommunityStandard-D6300: day 0Zymo-MicrobialCommunityStandard-D6300: day 8Zymo-MicrobialDNZymo-MicrobialDNAStandard-D6305: day 0Zymo-MicrobialDNAStandard-D6305: day 80 d3 mo5 mo8 mo11 mo

Each row is one person (26 shown); dots are samples at days since that person's first sample.

18 AN participants received capsules from a shared pool of multiple stool donors (multi-donor FMT); donor samples also included..

How longitudinal and relatedness information is derived

Community composition
Prevotella 13.4%Phocaeicola 7.0%Faecalibacterium 6.6%Bacteroides 6.3%Alistipes 4.5%Roseburia 3.6%Blautia_A 3.3%Acetatifactor 2.1%Bifidobacterium 1.7%Parabacteroides 1.5%Vescimonas 1.4%Lachnospira 1.4%not assigned to a genus 5.1%other genera 42.1%

Genera, mean relative abundance over 98 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category98 100%
country98 100%98
health_condition98 100%98
subject_id98 100%98
collection_date98 100%98
detailed_location98 100%
health_condition_detail98 100%98
location_locality98 100%98
location_site98 100%98
sex98 100%98
intervention92 94%92
timepoint_label66 67%66
intervention_detail63 64%63
Papers (1)
  • Encapsulated faecal microbiota transfer in young women with anorexia nervosa: an open-label feasibility pilot trial. 2025 PMID 41392089 PMC12808231 own_data
Details
Archive description

The Gut Bugs in Anorexia Nervosa trial was a one-arm, open-label feasibility pilot trial evaluated the tolerability and microbiological impact of encapsulated, multi-donor FMT in young women with AN (Registration: ACTRN12621001504808). The study was conducted in Auckland, New Zealand, between September 2022 and February 2024.</p><p>Eighteen participants were enrolled in a capsule-delivered, multi-donor FMT intervention, with 15 completing treatment. Each participant received 20 capsules containing concentrated gut microbiota from four different donors (5 capsules per donor), taken over one or two consecutive days. No bowel cleanse was performed prior to FMT for safety reasons. Given the 18 month recruitment phase, three separate FMT treatment batches were prepared with different combinations of donor microbiota.</p><p>Stool samples were collected at five time points: at enrolment (3 weeks before treatment), baseline (when treatment was administered), and 3, 6, and 12 weeks post-treatment. Stool samples were preserved in room-temperature-stable DNA/RNA Shield Fecal Collection Tubes (R1101, Zymo Research, Irvine, California, U.S.) before transfer to -80C for long-term storage. For donors, pre- and post-processing stool samples were collected at each donation and stored at -80C in DNA/RNA Shield.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Gut Bugs in Anorexia”
  • body site study.description · “The Gut Bugs in Anorexia”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.description · “FMT in young women with AN (Registration:”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN48745291collection_date2022-08-31R10.90biosample.attribute:collection_date2022-08-31
SAMN48745291countryNZR10.90sample.attr.geo_loc_nameNew Zealand: Auckland
SAMN48745291health_conditionother_diseaseR40.50study.descriptionyoung women with AN
SAMN48745291health_condition_detailanorexia nervosaR40.50study.descriptionyoung women with AN
SAMN48745291interventionfmtR10.90biosample.attribute:completed_fmtcompleted_fmt: Yes
SAMN48745357interventionno_interventionR10.70biosample.attribute:participant_typeDonor
SAMN48745291intervention_detailcompleted full course of FMT capsulesR10.90biosample.attribute:completed_fmtcompleted_fmt: Yes
SAMN48745291location_localityAucklandR10.85biosample.attribute:geo_loc_nameNew Zealand: Auckland
SAMN48745291location_siteLiggins Institute Clinical Research Unit, University of AucklandR30.70paper.fulltext.methodscarried out at the Liggins Institute Clinical Research Unit
SAMN48745291sexfemaleR30.70paper.fulltext.methodseligible participants were biological females aged
SAMN48745291subject_idAN-F01R10.85sample.attr.participant_idAN-F01
SAMN48745291timepoint_labelENR10.70biosample.attribute:sample_typeEN
Sequencing

98 runs over 98 samples · mean 6.08 Gbp per run (median 5.97 Gbp, total 595.86 Gbp; 98 runs with a base count) · layout PAIRED 98 · platform ILLUMINA 98 · models Illumina NovaSeq 6000 (98) · 100% of runs with a Sandpiper profile · first public 2025-12-22

Authors (12)

Wilson BC first · Tweedie-Cullen RY · Albert BB · Derraik JGB · Ho D · Depczynski M · Creagh C · Edwards T · Gali S · Thabrew H · Cutfield WS · O'Sullivan JM last

Downloads

PRJNA1268178.csv.gz (4.3 KB) · parquet (76.2 KB) — all 98 samples, every field with route and confidence · PRJNA1268178_determinations.csv.gz (7.5 KB) — 1,005 evidence rows

Samples (98 · every field this project has values for · hover a cell for its source)
Loading the sample table…